Furthermore, in the prophylactic setting, vaccination with anti-PSA IgE (AR47.47) and PSA complexes prolonged the survival of hFcεRI transgenic mice challenged with PSA-expressing CT26 tumour cells [48]. Here, IGHE is linked to neoplasm.